The benefits are many but a key one is MMCT's business model which puts surplus commercial funds back into local investigator led research and into the Investigators own department.
Experience in all departments
MMCT works with 22 medical departments of Middlemore
From mid-2020, it is expected MMCT will provide oncology clinical trials.
Assistance with trial setup
MMCT has a facilitating, budgeting, and ethics process that is swift and robust
MMCT can assist PI's (if required) with any cultural consultation and CM Health approvals
MMCT has expertise in recruiting
MMCT can assist with fuynding models and applications for funds
The team at MMCT has the ability to work in any and all phases of clinical development
MMCT’s dedicated staff will manage all budget negotiations with sponsors on your behalf.
The team will also help you secure funding for investigator initiated and collaborative group funded studies.
What the PI gets
Involvement in global studies
Access for your patients to novel medicines that otherwise are unavailable
Experience in novel medicines and new classes of medicines
Involvement with regional collaborative groups to research specific issues
Funding: Commercial trials as per our business model generate money for the researcher to spend on grant studies, collaborative group and even investigator initiated studies.
Located at New Zealand’s largest hospital
MMCT is based inside Middlemore Hospital, which is one of the largest tertiary hospitals in New Zealand, servicing 100,000 inpatients per year and nearly 500,000 outpatient visits. As such, MMCT has access to a large number of potential trial participants. This coupled with the clinical trial site’s relationships with community based primary care organisations (PHOs) means that MMCT connects with participants at multiple points along their treatment journey in the health care system.